Guardant Health (GH)
(Delayed Data from NSDQ)
$55.40 USD
+0.61 (1.11%)
Updated Sep 16, 2025 04:00 PM ET
After-Market: $56.09 +0.69 (1.25%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Guardant Health, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
GH 55.40 +0.61(1.11%)
Will GH be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for GH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GH
What's Fueling Tempus AI's Q2 Net Loss Improvement Momentum?
TMO Receives FDA Approval for Oncomine Dx Target Test
GH: What are Zacks experts saying now?
Zacks Private Portfolio Services
TEM Once Again Raises Its 2025 Sales Guidance: What's Driving the Move?
Guardant Health (GH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Guardant Health (GH) Reports Q2 Loss, Beats Revenue Estimates
Other News for GH
NR7 appears for GH after 0.19% move
Guardant Health Director Makes Significant Stock Sale!
Insider Sell: Medina Hidalgo Sells 2,165 Shares of Guardant Health Inc (GH)
Guardant Health Expands Board, Appoints Alex Azar
The technical outlook for GH is unchanged after it falls 3.35% on September 12